Aigen Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-3,714
Closed -$272K – 755
2025
Q3
$272K Buy
+3,714
New +$247K 0.04% 569
2024
Q2
– Sell
-24,033
Closed -$978K – 875
2024
Q1
$978K Buy
24,033
+15,091
+169% +$566K 0.21% 148
2023
Q4
$330K Buy
8,942
+2,361
+36% +$88.9K 0.06% 460
2023
Q3
$251K Buy
+6,581
New +$270K 0.05% 586
2022
Q3
– Sell
-23,084
Closed -$1.02M – 643
2022
Q2
$1.02M Sell
23,084
-2,211
-9% -$95.6K 0.17% 177
2022
Q1
$1.01M Buy
25,295
+10,769
+74% +$384K 0.17% 161
2021
Q4
$486K Buy
14,526
+2,703
+23% +$101K 0.03% 633
2021
Q3
$481K Buy
+11,823
New +$494K 0.09% 258
2021
Q2
– Sell
-20,593
Closed -$859K – 584
2021
Q1
$859K Sell
20,593
-12,189
-37% -$556K 0.11% 203
2020
Q4
$1.4M Sell
32,782
-17,097
-34% -$615K 0.18% 149
2020
Q3
$1.31M Buy
49,879
+41,717
+511% +$1.16M 0.17% 196
2020
Q2
$219K Buy
8,162
+5,205
+176% +$117K 0.03% 689
2020
Q1
$53K Sell
2,957
-37,575
-93% -$713K 0.01% 975
2019
Q4
$719K Buy
+40,532
New +$702K 0.12% 248

Other funds holding HALO

Aigen Investment Management's HALO Position: Q4 2025 in Review

Aigen Investment Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 3,714 shares — an estimated $272K sold.

Aigen Investment Management first reported a position in HALO in Q4 2019 and held it in 14 quarters. The position peaked at $1.4M in Q4 2020. 619 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Aigen Investment Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 3,714 Halozyme shares in Q4 2025, an estimated $272K.
  • Aigen Investment Management first reported a position in Halozyme in Q4 2019 and held it in 14 quarters.
  • Aigen Investment Management's Halozyme position peaked at $1.4M in Q4 2020.
  • 619 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.